Castle Biosciences Inc (NASDAQ:CSTL)

16.87
Delayed Data
As of Sep 29
 -0.50 / -2.88%
Today’s Change
9.26
Today|||52-Week Range
30.08
-28.33%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Castle Biosciences Inc have a median target of 32.50, with a high estimate of 40.00 and a low estimate of 25.00. The median estimate represents a +92.65% increase from the last price of 16.87.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Castle Biosciences Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.97
Sales
$44.0M
Reporting Date
Nov 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -38.85%
 
 
 
 
 
 
Growthannually -53.52%
 
 
 
 
 
 

Sales

Growthquarterly -12.31%
 
 
 
 
 
 
Growthannually 28.55%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.